FFP-104 is a humanized IgG4 monoclonal antibody inhibitor that targets TNFRSF5/CD40. VX70 is applicable for research into chronic autoimmune liver diseases, such as primary biliary cholangitis (PBC).
CAS Number:
[2378693-56-0]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
